Circulation, Vol 57, 366-372, Copyright © 1978 by American Heart Association
LM Mangiardi, RJ Hariman, RG McAllister Jr, V Bhargava, B Surawicz and R Shabetai
Verapamil was administered intravenously to 30 open-chest dogs and the
electrophysiologic and hemodynamic effects of the drug were correlated with
the corresponding plasma concentrations. At concentrations below 152 ng/ml,
verapamil prolonged the A-H interval, abolished ventriculoatrial
conduction, but did not significantly change sinus rate, cardiac output,
left ventricular dp/dt, of systemic vascular resistance. Concentrations
above 200 ng/ml were associated with slowing of the sinus rat, high degree
atrioventricular block during atrial pacing, 24% decrease in mean aortic
pressure, and decreased cardiac output and left ventricular dp/dt. Sinus
arrest, high degree atrioventicular block during sinus rhythm, decreased
systemic vascular resistance and increased left ventricular end-diastolic
pressure occurred when plasma verapamil concentrations exceeded 400 ng/ml.
These results show that plasma verapamil concentrations reliably reflect
the electrophysiologic and hemodynamic actions of the drug, and that
"therapeutic" drug effects can be achieved at plasma concentrations at
which myocardial depressant effects are unlikely.
ARTICLES
Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations
This article has been cited by other articles:
![]() |
J. I. Haft and M. A. Habbab Treatment of Atrial Arrhythmias: Effectiveness of Verapamil When Preceded by Calcium Infusion Arch Intern Med, June 1, 1986; 146(6): 1085 - 1089. [Abstract] [PDF] |
||||
![]() |
M. H. Hwang, J. Danoviz, I. Pacold, N. Rad, H. S. Loeb, and R. M. Gunnar Double-blind Crossover Randomized Trial of Intravenously Administered Verapamil: Its Use for Atrial Fibrillation and Flutter Following Open Heart Surgery Arch Intern Med, March 1, 1984; 144(3): 491 - 494. [Abstract] [PDF] |
||||
![]() |
C. Tommaso, T. McDonough, M. Parker, and J. V. Talano Atrial Fibrillation and Flutter: Immediate Control and Conversion With Intravenously Administered Verapamil Arch Intern Med, May 1, 1983; 143(5): 877 - 881. [Abstract] [PDF] |
||||
![]() |
B. N. Singh Pharmacological Basis for the Therapeutic Applications of Slow-Channel Blocking Drugs Angiology, August 1, 1982; 33(8): 492 - 515. [PDF] |
||||
![]() |
J. Kieval and R. J. Myerburg The Hemodynamic Effects of Calcium Channel Blocking Agents: A Brief Review Angiology, August 1, 1982; 33(8): 516 - 521. [PDF] |
||||
![]() |
H. L. WAXMAN, R. J. MYERBURG, R. APPEL, and R. J. SUNG Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or Flutter: A Double-Blind Randomized Cross-Over Study Ann Intern Med, January 1, 1981; 94(1): 1 - 6. [Abstract] [PDF] |
||||
![]() |
P. H. STONE, E. M. ANTMAN, J. E. MULLER, and E. BRAUNWALD Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications Ann Intern Med, December 1, 1980; 93(6): 886 - 904. [Abstract] [PDF] |
||||
![]() |
R. LAZZARA and B. SCHERLAG Treatment of Arrhythmias by Blocking Slow Current Ann Intern Med, December 1, 1980; 93(6): 919 - 921. [Abstract] [PDF] |
||||
![]() |
R. J. SUNG, B. ELSER, and R. G. McALLISTER Jr Intravenous Verapamil for Termination of Re-Entrant Supraventricular Tachycardias: Intracardiac Studies Correlated with Plasma Verapamil Concentrations Ann Intern Med, November 1, 1980; 93(5): 682 - 689. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1978 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |